Industrial advisors

Chris Rynning

Chris Rynning

China, Asia, cleantech, technology, finance

Phone:+47 47 688 123 E-mail: chris@staurholding.noLinkedInLinkedIn
Chris is a resident of China, having invested throughout Asia from his base in Beijing and Tokyo. He is a board member and has been Chairman of Norway Business Association China, in addition to lecturing in macro economics and private equity at Trondheim School of Business (HIST). Chris was the CEO of LSE listed Origo Partners for 8 years, after managing a PWC invested technology fund in Beijing. He was previously Regional Director of Elkem ASA and has broad transaction experience between Asia/China and Norway. Chris published the book "Little Streams, Big River" in 2014 about China's economic and environmental challenges. He also has broad experience as founder and investor of early stage growth companies in Norway and Europe. Chris Rynning graduated as Master of Science in Business from ESSEC, Paris, and holds an MBA in Finance from University of Chicago, USA.
Jan Fikkan

Jan Fikkan

Pharma, medtech, medical diagnostics

Phone:+47 911 92 145 E-mail: jan.fikkan@gmail.comLinkedInLinkedIn
Jan Fikkan is CEO of Fikkan Pharma and has 20+ years international leadership experience at a senior/executive level from the Pharmaceutical industry. He has held positions in R&D, Strategic Marketing, Strategic Planning, Business Intelligence, Business Development, Licensing as well as in various commercial roles. Currently he is President of the $1b, 1200 people Norwegian GE Healthcare unit. In addition I have P&L business responsibility for the Japan region within Medical Diagnostics. Specialties:Expertice in Japanese dealmaking from my 8 years experience from making R&D, licensing, supply and price agreements with various Japanese partners. Jan has closed deals with US, French, Swiss, UK and Austrian based companies and has been Board of Director in various local and international companies (including two Japanese). He has also been board member of Connect Norge since its creation in 2001.
Ståle Svenning

Ståle Svenning

Technology, growth, business development, M&A

Phone:+47 95 24 42 40 E-mail: stale.svenning@vilma.noLinkedInLinkedIn
Over the last 10 years, Ståle has served as CEO of three high-tech, entrepreneurial companies, all of them being acquired by major international industrial companies. Latest SmartMotor offering electrical machines operating in harsh environments acquired by Rolls Royce. Prior to entering the promised land of high-tech entrepreneurship, Ståle held posts such as COO and Head of Business Development at SpareBank1, Associate Principal with McKinsey & Company, Senior Consultant at Deloitte Management Consulting and Management Trainee at Orkla AS.
Carl Hall

Carl Hall

Cleantech, renewable energy

Phone:+46 705 68 57 06 E-mail: carl.t.hall@gmail.comLinkedInLinkedIn
Carl Hall is currently advisor to Alder and MVI Equity; a small cap private equity fund founded in 1992 by Volvo CEO Christer Zetterberg. He is also co-founder and board member of Lakers group.

Carl was previously co-founder and partner at Alder, the largest private equity company in the Nordic focusing on environmental technology companies, and he was Investment Director at Applied Value in New York.

Carl Hall has authored “Environmental Capitalists”, Lid Publishing (in Swedish: “Miljökapitalisterna”, Liber förlag), and he is actively engaged in promoting private equity trough the Swedish Venture Capital and Private Equity Association.
Knut Sandven

Knut Sandven

Technology, Nano/MEMS, sensors

Knut is an entrepreneur. He is currently part-time CEO for CrayoNano AS while developing a new possible start-up together with SINTEF. Knut was the founder and CEO of GasSecure AS, developing gas sensors based on MEMS technology. Investinor was one of the venture investors in GasSecure and followed the company from start to a successful exit. Knut also has experience from Idex, developing fingerprint sensors, as a researcher at SINTEF’s department for micro- and nanotechnology, and as advisor for various start-up companies. Knut is a board member at 4Subsea, delivering monitoring services and integrity assessment for subsea systems.
Jan Morten Ertsaas

Jan Morten Ertsaas

Oil &Gas

Jan Morten Ertsaas is CEO in Store Norske Spitsbergen Kulkompani. Prior to that he was Investment Director in Investinor. He has also been CEO of Safetec Nordic and Vice President, Offshore Oil & Gas Solutions at ABS Consulting. He has decades of in-depth experience and expertise from the oil and gas industry. During his 18 years at Statoil he served as e.g. Platform Manager, OIM, Pipeline Manager at Statoils South Pars project in Iran and R&D Director. Mr. Ertsaas holds an M.Sc. in marine engineering from the Norwegian University of Science and Technology (NTNU)
Laura Oliphant

Laura Oliphant

ICT

Phone: E-mail: LinkedInLinkedIn
Laura Oliphant is an experienced Board Director, CEO, and Venture Capital investor whose significant business results at Intel earned her Intel's highest award, Intel Achievement Award. At Intel, she delivered more than $1B in strategic value for her investments in semiconductor capital equipment, manufacturing robotics, SaaS, and device companies with a financial return in the top tier of venture investors. At Translarity, Laura executed a transformative M&A transaction that brought the company to immediate early revenue, and she completed a complex recapitalization. She is experienced in leading global cross-functional teams focusing on complex, strategic supplier relationship and logistics issues. She is a “financial expert,” as defined by the SEC.
Hilde Furberg

Hilde Furberg

Pharma

Phone: E-mail: hilde@furberg.dkLinkedInLinkedIn
Hilde Furberg is an independent consultant and a professional board member. She has broad senior leadership experience, coming from her 35 years in sales, marketing, strategy and general management in Pharma/Biotech. Her experience is in different areas of specialty care, and from small to large global companies. Hilde has worked in companies like Baxter and Genzyme, she was most recently European Head of Rare Diseases for Sanofi Genzyme.
In addition to working for Genzyme/Sanofi Genzyme Hilde has since 2005 been a non-executive director and board member of Probi, Pronova, Clavis and Algeta.
She is currently an industrial advisor to Investinor and board member of BerGenBio, Calliditas, Tappin and CoB for Blueprint Genetic.
Hilde holds a Master of Science from the University of Oslo (Norway).